Assignee
HANX BIOPHARMACEUTICS INC
CN·2 granted patents·1 pending application·0 citations·filing 2018–2020
Top patents by PatentIndex Score
3 records- 0143US11680099B2Anti-PD-1/CD47 bispecific antibody and application thereofHANX BIOPHARMACEUTICS INC·Filed 2020·Granted Jun 20, 2023·0 cites·10 claims
- 0240US12195545B2Anti-OX40 monoclonal antibody and application thereofHANX BIOPHARMACEUTICS INC·Filed 2018·Granted Jan 14, 2025·0 cites·19 claims
- 0338US2019330313A1Method for increasing binding affinity of igg-like antibody to fcrn and prolonging serum half-life thereofHANX BIOPHARMACEUTICS INC·Filed 2019·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →